SynCardia Systems, LLC., a Picard Medical Inc. company, is pleased to announce that the United States Patent and Trademark Office (USPTO) has issued a second patent (US patent no. 12,121,711 B2) that will expand the coverage of SynCardia’s fully implantable artificial heart technology (SynCardia Emperor). The USPTO allowed the first patent (US patent no. 11,918,797) relating to its groundbreaking “Next Generation Total Artificial Heart” designs in March of this year.
Tag: cardiac output
Scientists ID Localized P2X7 Receptor as a Key to a Healthy Heart
Research in mice has found the P2X7 receptor (P2X7R) to be a key regulator of mitochondrial energy metabolism that enhances physical fitness. P2X7R is a channel that becomes activated in response to ATP, the organic compound that gives the body…